Category

Cohort News

Concord Health Partners Portfolio Companies NeuroFlow and Iris TeleHealth Complete Acquisitions to Enhance Leading Behavioral Health Capabilities

//
Categories
SUMMIT, N.J., Feb. 11, 2025 /PRNewswire/ — Concord Health Partners (“Concord”), a healthcare focused investment firm, today announced recent transactions by two of its behavioral health portfolio companies. Iris TeleHealth (“Iris”), a leading provider of transformative behavioral health services for...
Read More →

Sibel Announces its 4th FDA Clearance for Continuous Wearable Vital Signs Monitoring with ANNE® One and Additional Strategic Collaboration with Ann & Robert H. Lurie Children’s Hospital of Chicago

//
Categories
Expanded Indication Includes Adolescents, Ambulatory ECG, Continuous SpO2, and Non-Invasive Blood Pressure in the Home or Hospital Setting. CHICAGO, Feb. 7, 2024 /PRNewswire/ — Sibel Health, a leading digital health company, announced today that its continuous wearable monitoring solution, ANNE®...
Read More →

Arsenal Medical Announces Complete Enrollment of the Initial Cohort in the EMBO-02 Study Assessing NeoCast™ for the Treatment of Chronic Subdural Hematoma

//
Categories
WALTHAM, Mass. — Arsenal Medical, a clinical-stage company developing medical devices from innovative biomaterials, today announced the complete enrollment of an initial cohort of 10 patients in the EMBO-02 clinical study of NeoCast™ to treat chronic subdural hematomas (cSDH) across...
Read More →

Gyder Surgical Announces 510(k) FDA clearance for the GYDER® Hip System, the World’s First Commercially Available Pin-less and Image-less Solution for Accurate Positioning of the Acetabular Cup during Anterior Hip Arthroplasty

//
Categories
MULGRAVE, Australia & PALO ALTO, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) — Gyder Surgical, a MedTech company specializing in intuitive, orthopaedic navigation solutions, today announced the 510(k) FDA clearance for the GYDER® Hip System, the world’s first commercially available non-invasive...
Read More →